GeoWealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Buy
10,643
+139
+1% +$21.3K 0.06% 190
2025
Q4
$1.45M Buy
10,504
+146
+1% +$19.1K 0.05% 210
2025
Q3
$1.33M Buy
10,358
+7,137
+222% +$871K 0.05% 245
2025
Q2
$390K Sell
3,221
-640
-17% -$72.1K 0.02% 470
2025
Q1
$430K Sell
3,861
-3,057
-44% -$325K 0.02% 457
2024
Q4
$673K Buy
6,918
+4,606
+199% +$491K 0.02% 402
2024
Q3
$266K Sell
2,312
-1,843
-44% -$209K 0.01% 636
2024
Q2
$442K Buy
4,155
+114
+3% +$11.4K 0.02% 464
2024
Q1
$391K Buy
4,041
+1,465
+57% +$150K 0.02% 500
2023
Q4
$259K Buy
+2,576
New +$249K 0.02% 443

Other funds holding NVS

GeoWealth Management's NVS Position: Q1 2026 in Review

GeoWealth Management increased its Novartis (NVS) stake by 1.3% in Q1 2026, buying an estimated $21.3K and bringing the position to 10,643 shares worth $1.63M. The position accounts for 0.06% of the portfolio, ranked #190.

GeoWealth Management first reported a position in NVS in Q4 2023 and has held it in 10 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • GeoWealth Management held 10,643 shares of Novartis worth $1.63M as of Q1 2026.
  • GeoWealth Management bought 139 Novartis shares in Q1 2026, an estimated $21.3K.
  • Novartis made up 0.06% of GeoWealth Management's portfolio in Q1 2026, its #190 holding.
  • GeoWealth Management first reported a position in Novartis in Q4 2023 and has held it in 10 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on GeoWealth Management's 13F filing for Q1 2026, filed 13 May 2026.